Bone turnover and inhaled corticosteroids

Packe, G E; Douglas, J G
January 1995
Thorax;Jan1995, Vol. 50 Issue 1, p103
Academic Journal
No abstract available.


Related Articles

  • Asthma, Inhalers, and Your Bones.  // Running & FitNews;Jul/Aug2002, Vol. 20 Issue 7, p1 

    Provides information on the effect of inhaled corticosteroids for asthma on bone density.

  • Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Reid, D.M.; Nicoll, J.J.; Smith, M.A.; Higgins, B.; Tothill, P.; Nuki, G. // British Medical Journal (Clinical Research Edition);12/6/1986, Vol. 293 Issue 6560, p1463 

    Examines on corticosteroids and bone mass in asthma. Comparisons with rheumatoid arthritis and polymyalgia rheumatica; Analysis of patients as recipients of treatments for asthma; Reduction of body calcium in patients inhaled corticosteroids; Assessment of losses of bone associated with the...

  • Inhaled Corticosteroid Therapy for Asthma. Morantz, Carrie; Torrey, Brian // American Family Physician;3/1/2004, Vol. 69 Issue 5, p1309 

    Deals with the report "Systematic Review of the Evidence Regarding Potential Complications of Inhaled Corticosteroid Use in Asthma," issued by the American College of Chest Physicians, the American Academy of Allergy, Asthma and Immunology, published in the December 2003 issue of the journal...

  • Impact of Inhaled and Intranasal Corticosteroids on the Growth of Children. Wolthers, O.D. // BioDrugs;2000, Vol. 13 Issue 5, p347 

    Since inhaled and intranasal corticosteroids may be systemically bioavailable, risk of growth suppression cannot be ruled out in children treated with these compounds. The mechanisms by which exogenous corticosteroids can cause growth suppression may be multifactorial, involving influences on...

  • Beclomethasone inhalation decreases serum osteocalcin concentrations. Pouw, Ellen M.; Prummel, Mark F.; Oosting, Hans; Roos, Carel M.; Endert, Erik // BMJ: British Medical Journal (International Edition);2/16/91, Vol. 302 Issue 6773, p627 

    Examines the effects of beclomethasone inhalation on osteocalcin concentrations. Effectiveness of inhaled corticosteroids in treating bronchial asthma; Influence of the long term treatment of oral corticosteriods in the development of osteoporosis; Depression of bone formation.

  • Inhaled corticosteroids appear to have little risk of causing adverse effects on growth, bone density or cortisol levels in children with asthma.  // Drugs & Therapy Perspectives;Jul2007, Vol. 23 Issue 7, p21 

    A systematic review of studies of the long-term use of inhaled corticosteroids in children with asthma suggests that recommended doses of inhaled corticosteroids can be administered to children for the long-term management of asthma with minimal risk of clinically relevant adverse effects on...

  • Management of severe hypercalcaemia.  // British Medical Journal;1/26/1980, Vol. 280 Issue 6209, p204 

    Focuses on the management of severe hypercalcemia. Correction of volume depletion by infusing saline; Use of corticosteroids to lower the serum calcium concentrations; Suppression of bone turnover by calcitonin.

  • Inhaled budesonide and bone formation in children. Joyce, Terrence J. // American Family Physician;6/1/1998, Vol. 57 Issue 11, p2819 

    Discusses the effectiveness which the anti-inflammatory medicines such as inhaled corticosteroids in reference to the treatment of asthma. Hesitation of physicians in prescribing inhaled corticosteroids for children due to the possible adverse effects on bone growth and information; Evaluation...

  • Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing. Newnham, D.M. // Drug Safety;Nov2001, Vol. 24 Issue 14, p1065 

    The incidence of drug-induced adverse effects is likely to increase as a result of advanced age and exposure of elderly patients to polypharmacy. Therefore, pharmacological therapy of asthma and chronic obstructive pulmonary disease (COPD) in the elderly patient can be potentially hazardous....

  • Inhaled corticosteroids may carry less risk of BMD reduction in postmenopausal women.  // Formulary;Apr2003, Vol. 38 Issue 4, p193 

    Discusses the results of a study showing that moderate doses of inhaled corticosteroids carry less risk than traditional oral corticosteroid therapy with respect to reduction of bone mineral density (BMD) in post-menopausal women. Overview of the study; Effect of oral glucocorticoid treatment...


Read the Article


Sign out of this library

Other Topics